1.
Jackson J, Eaton W, Cascella N, et al. Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia. Schizophr Res. 2014;159(2-3):539-42. doi:10.1016/j.schres.2014.09.023.
1.
Sumner JA, Duncan L, Ratanatharathorn A, Roberts AL, Koenen KC. PTSD has shared polygenic contributions with bipolar disorder and schizophrenia in women. Psychol Med. 2016;46(3):669-71. doi:10.1017/S0033291715002135.
1.
Vilhjálmsson BJ, Yang J, Finucane HK, et al. Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores. Am J Hum Genet. 2015;97(4):576-92. doi:10.1016/j.ajhg.2015.09.001.
1.
Weïwer M, Lewis MC, Wagner FF, Holson EB. Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia. Future Med Chem. 2013;5(13):1491-508. doi:10.4155/fmc.13.141.
1.
Ruderfer DM, Lim ET, Genovese G, et al. No evidence for rare recessive and compound heterozygous disruptive variants in schizophrenia. Eur J Hum Genet. 2015;23(4):555-7. doi:10.1038/ejhg.2014.228.
1.
Loh P-R, Bhatia G, Gusev A, et al. Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis. Nat Genet. 2015;47(12):1385-92. doi:10.1038/ng.3431.
1.
Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet. 1996;58(6):1347-63.
1.
Raychaudhuri S, Plenge RM, Rossin EJ, et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 2009;5(6):e1000534. doi:10.1371/journal.pgen.1000534.
1.
Rees E, Walters JTR, Georgieva L, et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry. 2014;204(2):108-14. doi:10.1192/bjp.bp.113.131052.
1.
Hyman S. Mental health: depression needs large human-genetics studies. Nature. 2014;515(7526):189-91. doi:10.1038/515189a.